Cyclo Therapeutics (CYTH) Insider Trading & Ownership

$1.33
+0.03 (+2.31%)
(As of 04/25/2024 ET)

Cyclo Therapeutics (NASDAQ:CYTH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
29.78%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$5 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get CYTH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cyclo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CYTH Insider Buying and Selling by Quarter

Cyclo Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/1/2023Rafael Holdings, Inc.Major ShareholderBuy4,000,000$1.25$5,000,000.00  
(Data available from 1/1/2013 forward)

CYTH Insider Trading Activity - Frequently Asked Questions

Who is on Cyclo Therapeutics's Insider Roster?

The list of insiders at Cyclo Therapeutics includes Francis Patrick Ostronic, Jeffrey Tate, Markus Sieger, N Scott Fine, Rafael Holdings, Inc., and Sharon Hemond Hrynkow. Learn more on insiders at CYTH.

What percentage of Cyclo Therapeutics stock is owned by insiders?

29.78% of Cyclo Therapeutics stock is owned by insiders. Learn more on CYTH's insider holdings.

Which Cyclo Therapeutics insiders have been buying company stock?

The following insiders have purchased CYTH shares in the last 24 months: Francis Patrick Ostronic ($27,800.00), Jeffrey Tate ($29,205.61), Markus Sieger ($42,515.51), N Scott Fine ($212,575.42), and Rafael Holdings, Inc. ($5,000,000.00).

How much insider buying is happening at Cyclo Therapeutics?

Insiders have purchased a total of 4,407,859 CYTH shares in the last 24 months for a total of $5,312,096.54 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:CYTH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners